<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T1" position="float">
 <label>Table 1</label>
 <caption>
  <p>Characteristics of the patients treated with DAAs and comparison of serum alanine aminotransferase (ALT), liver iron concentration (LIC), and serum ferritin values between baseline and after treatment at the SVR evaluation.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <tbody>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <bold>Patients, 
      <italic>n</italic>
     </bold>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">
     <bold>34</bold>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" colspan="2" rowspan="1">
     <bold>Age, years</bold>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   Mean ± SD</td>
    <td valign="top" align="center" rowspan="1" colspan="1">44 ± 7</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   Range</td>
    <td valign="top" align="center" rowspan="1" colspan="1">32–59</td>
   </tr>
   <tr>
    <td valign="top" align="left" colspan="2" rowspan="1">
     <bold>Gender, 
      <italic>n</italic> (%)
     </bold>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   Male (M)</td>
    <td valign="top" align="center" rowspan="1" colspan="1">15 (44.1%)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   Female (F)</td>
    <td valign="top" align="center" rowspan="1" colspan="1">19 (55.9%)</td>
   </tr>
   <tr>
    <td valign="top" align="left" colspan="2" rowspan="1">
     <bold>Hemoglobinopathy, 
      <italic>n</italic> (%) (M/F)
     </bold>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   Thalassemia major (TM)</td>
    <td valign="top" align="center" rowspan="1" colspan="1">28 (82.4%) 16F/12M</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   Thalassemia intermedia (TI)</td>
    <td valign="top" align="center" rowspan="1" colspan="1">3 (8.8%) 2F/1M</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   Sickle cell disease (SCD)</td>
    <td valign="top" align="center" rowspan="1" colspan="1">3 (8.8%) 1F/2M</td>
   </tr>
   <tr>
    <td valign="top" align="left" colspan="2" rowspan="1">
     <bold>HCV genotype, 
      <italic>n</italic> (%)
     </bold>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   G1a</td>
    <td valign="top" align="center" rowspan="1" colspan="1">3 (8.8%)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   G1b</td>
    <td valign="top" align="center" rowspan="1" colspan="1">17 (50%)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   G2a</td>
    <td valign="top" align="center" rowspan="1" colspan="1">5 (14.7%)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   G2a/2b</td>
    <td valign="top" align="center" rowspan="1" colspan="1">1 (2.9%)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   G2a/2c</td>
    <td valign="top" align="center" rowspan="1" colspan="1">2 (5.8%)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   G3</td>
    <td valign="top" align="center" rowspan="1" colspan="1">2 (5.8%)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   G4</td>
    <td valign="top" align="center" rowspan="1" colspan="1">4 (11.7%)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Liver stiffness, KPa (range)</td>
    <td valign="top" align="center" rowspan="1" colspan="1">10.0–34.8</td>
   </tr>
   <tr>
    <td valign="top" align="left" colspan="2" rowspan="1">
     <bold>Iron chelation, mg/Kg/day (days)</bold>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   DFO</td>
    <td valign="top" align="center" rowspan="1" colspan="1">30–40 (5–7 days)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   DFX</td>
    <td valign="top" align="center" rowspan="1" colspan="1">25–35 (7 days)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   DFP</td>
    <td valign="top" align="center" rowspan="1" colspan="1">60–75 (7 days)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   DFO + DFP</td>
    <td valign="top" align="center" rowspan="1" colspan="1">25–40 (3–4 days) + 75 (7 days)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   DFO + DFX</td>
    <td valign="top" align="center" rowspan="1" colspan="1">25–30 (3–6 days) + 20–35 (1–4 days)</td>
   </tr>
   <tr>
    <td valign="top" align="left" colspan="2" rowspan="1">
     <bold>Comorbidities, 
      <italic>n</italic> (%)
     </bold>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   Heart disease</td>
    <td valign="top" align="center" rowspan="1" colspan="1">5 TM (14.7%)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   Essential thrombocytopenia</td>
    <td valign="top" align="center" rowspan="1" colspan="1">1 TM (2.9%)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   Kidney disease</td>
    <td valign="top" align="center" rowspan="1" colspan="1">2 SCD (5.9%)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   Pulmonary embolism</td>
    <td valign="top" align="center" rowspan="1" colspan="1">1 TM (2.9%)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   Crioglobulinemia and neuropathy</td>
    <td valign="top" align="center" rowspan="1" colspan="1">1TM (2.9%)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   Hepato cellular carcinoma</td>
    <td valign="top" align="center" rowspan="1" colspan="1">1TM (2.9%)</td>
   </tr>
   <tr>
    <td valign="top" align="left" colspan="2" rowspan="1">
     <bold>Serum ALT, IU/L (mean ± SD, range)</bold>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   Before therapy</td>
    <td valign="top" align="center" rowspan="1" colspan="1">44.0 ± 30.1 (9–124)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   After therapy
     <break/>   
     <italic>p</italic> = 0.018
     <xref ref-type="table-fn" rid="TN1">
      <sup>*</sup>
     </xref>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">24.1 ± 21.8 (8–99)</td>
   </tr>
   <tr>
    <td valign="top" align="left" colspan="2" rowspan="1">
     <bold>LIC, mg Fe/g liver d.w. (mean ± SD, range)</bold>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   Before therapy</td>
    <td valign="top" align="center" rowspan="1" colspan="1">1.85 ± 1.22 (0.9–5.7)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   After therapy
     <break/>   
     <italic>p</italic> = 0.626
     <xref ref-type="table-fn" rid="TN1">
      <sup>*</sup>
     </xref>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">1.66 ± 0.72 (0.9–3.2)</td>
   </tr>
   <tr>
    <td valign="top" align="left" colspan="2" rowspan="1">
     <bold>Serum Ferritin, ng/mL (mean ± SD, range)</bold>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   Before therapy</td>
    <td valign="top" align="center" rowspan="1" colspan="1">429 ± 355 (111–1594)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">   After therapy
     <break/>   
     <italic>p</italic> = 0.150
     <xref ref-type="table-fn" rid="TN1">
      <sup>*</sup>
     </xref>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">536 ± 528 (87–2199)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="TN1">
   <label>*</label>
   <p>
    <italic>Students' t-test for paired data</italic>.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
